Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "SUIT-004 O2 pfi D010"

From Bioblast
Line 31: Line 31:
== Strengths and limitations ==
== Strengths and limitations ==


:::*A succinate concentration of >10 mM may be required for saturating SE capacity.
:::* A succinate concentration of >10 mM may be required for saturating SE capacity.
::::* CIV assessment is skipped if a prolonged protocol is not practical due to time limitation.
::::# '''RP1-6Ama''' may be skipped since correction of the initial states by ROX measured in RP1-6 Ama may represent an over-correction, and inhibition takes a very long time in several cases ([[Pesta 2012 Methods Mol Biol]]).
:::+ Linear coupling control (L-P-E) with N substrates (PM).
:::+ Linear coupling control (L-P-E) with N substrates (PM).
:::+ Pathway control in ET state (N, NS and S pathways).
:::+ Pathway control in ET state (N, NS and S pathways).
:::+ This protocol can be extended with the Complex IV module.
:::+ This protocol can be extended with the Complex IV module.
:::+ Short experimental time.
:::+ Short experimental time.
:::- The substrate combination for maximum ET capacity (FNSGP) is not obtained in SUIT-004 in favor of reducing the exper
:::- The substrate combination for maximum ET capacity (FNSGP) is not obtained in SUIT-004 in favor of reducing the time consumed during the experiment.


== Compare SUIT protocols ==
== Compare SUIT protocols ==
:::* [[SUIT-001 O2 pfi D002]]


:::'''Specific cases'''
:::'''Specific cases'''
Line 44: Line 48:
::::* [[Permeabilized muscle fibres |pfi]], high O<sub>2</sub>, no ROX: NS(PM)01_pfiO2,1PM,2D(c),3U,4S,5Rot
::::* [[Permeabilized muscle fibres |pfi]], high O<sub>2</sub>, no ROX: NS(PM)01_pfiO2,1PM,2D(c),3U,4S,5Rot


::::* The '''[[SUIT-004]]''' protocol is linked to [[SUIT-001 O2 pfi D002]] for healthy human skeletal muscle mitochondria on the basis of the following rationale.


::::# The first coupling control steps (1-4) are identical.
 
::::# '''RP1-5G''' is skipped, since [[PM]] and [[PGM]] yield nearly identical OXPHOS capacity. However, [[PM]]<[[PGM]] is a potential diagnostic for a defect in the PM-linked pathway upstream of CI.
 
::::# '''RP1-7Oct''' is skipped, since octanoylcarnitine exerts practically no stimulatory effect on OXPHOS capacity in state [[PMS]] or [[PGMS]], but in conjunction with prolonged exposure may even yield a slight decline of respiration.
 
::::# '''RP1-9Gp''' is skipped, since glycerolphosphate exerts only a minor stimulatory effect on OXPHOS capacity in state [[SRot]].
::::# Omission of the three steps described above shortens the SUIT protocol, thus reducing the risk of diminishing respiratory capacity over time, reducing the number of necessary reoxygenations, and providing more time for detailed evaluation of steady-states. The loss of diagnostic information may be minor relative to the benefits of simplification of the protocol, particularly in studies of exercise in healthy humans.
::::# '''RP1-10Ama''' may be skipped, since correction of the initial states by ROX measured in RP1-10 Ama may represent an over-correction, and inhibition takes a very long time in several cases ([[Pesta 2012 Methods Mol Biol]]).
::::# '''RP1-11Tm''' and '''RP1-12Azd''' are skipped, if a prolonged protocol is not practical due to limination of time.


{{MitoPedia concepts
{{MitoPedia concepts

Revision as of 16:58, 30 January 2019


high-resolution terminology - matching measurements at high-resolution


SUIT-004 O2 pfi D010

Description

1PM;2D;2c;3U;4S;5Rot;6Ama;7AsTm;8Azd.pngSUIT 004.png

Abbreviation: NS(PM)

Reference: A: SUIT-004 short protocol linked to SUIT-001 O2 pfi D002 - SUIT RP1 (human skeletal muscle)

SUIT number: D010_1PM;2D;2c;3U;4S;5Rot;6Ama;7AsTm;8Azd

O2k-Application: O2

SUIT-category: NS(PM)
SUIT protocol pattern: orthogonal 1PM;2D;2c;3U;4S;5Rot


Communicated by Iglesias-Gonzalez J and Gnaiger E (last update 2019-01-21)

References

MitoPedia: SUIT

Steps and respiratory states

1PM;2D;2c;3U;4S;5Rot;6Ama;7AsTm;8Azd.png

Step State Pathway Q-junction Comment - Events (E) and Marks (M)
1PM PML(n) N CI 1PM
2D PMP N CI 1PM;2D
2c PMcP N CI 1PM;2D;2c
3U PME N CI 1PM;2D;3U
4S PMSE NS CI&II 1PM;2D;3U;4S
  • Respiratory stimulation by simultaneous action of type N substrates & succinate, with convergent electron flow in the NS-pathway for reconstitution of TCA cycle function.
  • Noncoupled electron transfer state, ET state, with ET capacity E.
5Rot SE S CII 1PM;2D;3U;4S;5Rot
6Ama ROX 1PM;2D;3U;4S;5Rot;6Ama
  • Rox is the residual oxygen consumption in the ROX state, due to oxidative side reactions, estimated after addition of antimycin A (inhibitor of CIII). Rox is subtracted from oxygen flux as a baseline for all respiratory states, to obtain mitochondrial respiration (mt).
Step Respiratory state Pathway control ET-Complex Comment
## AsTm AsTmE CIV CIV
## Azd CHB


Questions.jpg


Click to expand or collaps

Strengths and limitations

  • A succinate concentration of >10 mM may be required for saturating SE capacity.
  • CIV assessment is skipped if a prolonged protocol is not practical due to time limitation.
  1. RP1-6Ama may be skipped since correction of the initial states by ROX measured in RP1-6 Ama may represent an over-correction, and inhibition takes a very long time in several cases (Pesta 2012 Methods Mol Biol).
+ Linear coupling control (L-P-E) with N substrates (PM).
+ Pathway control in ET state (N, NS and S pathways).
+ This protocol can be extended with the Complex IV module.
+ Short experimental time.
- The substrate combination for maximum ET capacity (FNSGP) is not obtained in SUIT-004 in favor of reducing the time consumed during the experiment.

Compare SUIT protocols

Specific cases
  • imt, ROX: NS(PM)01_imt,1PM,2D(c),3U,4S,5Rot,6Ama
  • pfi, high O2, no ROX: NS(PM)01_pfiO2,1PM,2D(c),3U,4S,5Rot




MitoPedia concepts: SUIT protocol, SUIT A, Find 


MitoPedia methods: Respirometry